The Cancer Risk of Pioglitazone among Patients with Type 2 Diabetes: from Nested Case-Control Study to Cohort Study with Time-Varying Exposure

See, Lai-Chu (PI)
Huang, Wen-Kuan (CoPI)
Yang, Huang-Yu (CoPI)
Yen, Chieh Li (CoPI)

Project: National Science and Technology Council › National Science and Technology Council Academic Grants

Abstract

本研究採用健保資料庫、死亡登記檔，探討糖尿病病人使用pioglitazone對日後罹患癌症的風險。提供臨床醫師具體的數據作為醫生與病患溝通選擇哪種藥物的安全性評估，並提供健保主管機關藥物給付治療目標族群後的整體治療效益評估。

Project IDs

Project ID:PC11107-5258
External Project ID:MOST111-2314-B182-016

Status	Finished
Effective start/end date	01/08/22 → 31/07/23

Keywords

pioglitazone
type 2 diabetes
cancer risk
PPAR-γ

Access Project

https://www.grb.gov.tw/search/planDetail?id=14508384